This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific has recalled a group of Accolade ...
Medical device major Boston Scientific Corporation (BSX) recently launched its Accolade family of pacemakers in the European market, after winning the CE (Conformité Européenne) Mark approval for the ...
On Aug 28, we issued an updated research report on Boston Scientific Corporation BSX. Boston Scientific’s recent acquisitions have added various new products (though many are under development) with ...
Elizabeth Fletcher, 69, experienced two brushes with death in eight years after her pacemakers suddenly stopped working - the ...
TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration. The ...
Boston Scientific has announced it has received FDA approval its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers, according to a news release. The INGENIO and ...
Guidant, a subsidiary of Natick, Mass.-based Boston Scientific, has agreed to pay $9.25 million to settle False Claims Act charges over the company’s alleged cost inflation for pacemakers and ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Analysts remain high on Boston Scientific after a visit to the company's Marlborough, Massachusetts headquarters.
(Reuters) -Boston Scientific increased its annual profit forecast on Wednesday, fueled by strong demand for its cardiac implants, but temporarily halted a pivotal heart equipment study citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results